Deals & Cases | 21 Mar 2017

Froriep advised the founders and shareholders of AG with regard to a €20 million equity investment from invus

FRORIEP advised the founders and shareholders of AG with regard to a €20 million investment made by Invus, an equity investor with offices in New York, London, Paris and Hong Kong investing in companies across a wide range of industries including consumer products and services, specialty retail, software, biotech and medical devices. AG has initiated and continues to drive development of the renowned open source KNIME Analytics Platform, the leading open solution for data-driven innovation, designed for discovering the potential hidden in data, mining for fresh insights, or predicting new futures.

FRORIEP’s work included negotiating and drafting the transaction documents and closing items, including an investment agreement and a shareholders’ agreement, and all of the corporate actions and documents for the implementation and execution of the share capital increase. AG was advised by FRORIEP in Zurich and Zug, and Taylor Wessing in Hamburg. The FRORIEP team consisted of Dr. Mark Montanari (Corporate and M&A),  Evelien Zemp (Corporate and Notarial Services) as well as Benjamin Dürig (Corporate and M&A) lead by Catrina Luchsinger.

FRORIEP > Where do we work?

Where do we work?
We are Swiss-oriented but think internationally, to serve the needs of our clients wherever they arise.